Patients with T2D who undergo kidney transplants are less likely to experience organ failure and mortality if they receive ...
The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback